THE EDUCATION LIBRARY
Education concepts
Use a concept to answer one question; use a guide to learn toward a goal. These summaries and the glossary definitions are generated from the concept pages. Domain and learner review remain pending where stated on each page.
Biology basics
| Concept | In one sentence |
|---|---|
| Central dogma: from DNA to RNA to protein | For a protein-coding gene, cells transcribe DNA into RNA and translate the RNA into protein. |
Breast cancer and pathology
| Concept | In one sentence |
|---|---|
| TNM staging | TNM staging describes the primary tumor, regional lymph nodes and distant metastasis using a cancer-specific classification. |
| Pathologic complete response (pCR) | Pathologic complete response means no residual invasive cancer in the breast or sampled regional nodes after neoadjuvant treatment. |
| Residual cancer burden (RCB) | Residual cancer burden combines breast tumor-bed measurements and regional-node findings into a score after neoadjuvant treatment. |
| Surgical margins | A surgical margin is the edge of removed tissue, examined to determine whether cancer reaches that edge. |
Engineering and manufacturing
| Concept | In one sentence |
|---|---|
| LNP (lipid nanoparticle) | A lipid nanoparticle is a formulated lipid carrier that can protect RNA and help deliver it into cells. |
| mRNA construct anatomy | An mRNA construct combines a protein-coding message with sequence features that influence its translation, stability and processing. |
Evidence and statistics
| Concept | In one sentence |
|---|---|
| Clinical actionability | Clinical actionability asks whether a finding supports a specific medical decision in the relevant disease and treatment setting. |
| Prognostic versus predictive biomarkers | A prognostic biomarker is associated with outcome, while a predictive biomarker identifies differences in the effect of a particular treatment. |
| Hazard ratio | A hazard ratio compares the event hazards of two specified groups over follow-up. |
| Kaplan–Meier curves | A Kaplan–Meier curve estimates the probability of remaining free of a defined event over time while accounting for incomplete follow-up. |
| Survival endpoints | A survival endpoint specifies the starting time and which events count during follow-up. |
| Lead-time bias | Lead-time bias occurs when earlier detection lengthens measured survival from diagnosis without changing when the outcome occurs. |
| Positive predictive value and base rates | Positive predictive value is the probability of the defined condition among people with a positive test result. |
Immunology
| Concept | In one sentence |
|---|---|
| Antigen-processing machinery | Antigen-processing machinery generates protein fragments and loads them onto display molecules for T-cell inspection. |
| B2M (beta-2 microglobulin) | Beta-2 microglobulin supports the assembly and stable surface expression of classical human leukocyte antigen class-I complexes. |
| Cross-presentation | Cross-presentation occurs when a cell displays externally acquired antigen on class-I human leukocyte antigen molecules. |
| HLA (human leukocyte antigen) | HLA molecules display protein fragments for T-cell recognition. |
| Neoantigen | A neoantigen is an immune-recognition target arising from a tumor-specific sequence alteration. |
| T-cell priming and the three-signal model | T-cell priming is the initial activation of a naive T cell by antigen recognition and a supporting signal context. |
| T-cell states | T-cell states describe changing differentiation and functional programs, rather than simply whether a T cell is present. |
| TCR (T-cell receptor) | A conventional alpha-beta T-cell receptor recognizes a peptide together with the human leukocyte antigen molecule displaying it. |
| Innate vs adaptive immunity | Innate immunity uses inherited sensing systems, while adaptive immunity expands cells with diverse antigen-specific receptors. |
| The immune-cell roster | Immune cells perform different sensing, presentation, killing, antibody-producing and regulatory jobs that depend on their state and location. |
| Immune escape | Immune escape occurs when cancer cells survive by avoiding recognition, access or effective immune attack. |
Measurement and assays
| Concept | In one sentence |
|---|---|
| ctDNA (circulating tumor DNA) units and detection limits | A circulating tumor DNA number is meaningful only with the assay’s measured quantity, units and detection criteria. |
Treatment mechanisms
| Concept | In one sentence |
|---|---|
| CAR (chimeric antigen receptor) anatomy | A chimeric antigen receptor connects an external antigen-binding region to internal signaling machinery in an engineered immune cell. |
Terminology provides quick definitions, including legacy entries that have not yet become concept pages.